The B-POISED study
Start date
01 September 2024End date
31 May 2026Background
NHS England recommends cancer services set up ‘Personalised Stratified Follow Up’ (PSFU) starting with breast, prostate and colorectal cancers. This means patients who feel well do not attend hospital for routine ‘check-ups’ following treatment. Instead, they should contact their specialist team when they need to see them. Research has found that PSFU is a safe and effective way of monitoring people after treatment. However, it requires patients to monitor their health and report symptoms. PSFU safety and effectiveness may differ for certain people such as those on low incomes, living in remote areas or from minority ethnic backgrounds, sometimes called ‘under-served groups’.
The aim of this study is to find out if PSFU meets the needs of people from under-served groups following treatment for breast cancer, and to make recommendations to improve PSFU experience.
Study design
This project involves 3 phases or ‘workstreams’:
- Workstream 1 (WS1) will find out what is already known about PSFU in breast cancer.
- In workstream 2 (WS2), we will interview NHS staff involved in implementing and delivering PSFU at cancer alliances across England, as well as professionals who support people with breast cancer through charities, to explore their experiences of PSFU. Cancer alliances will be selected to ensure we include people from various under-served groups.
- Workstream 3 (WS3) will involve interviewing people who have completed treatment for breast cancer and have entered a PSFU pathway. We will include people from under-served groups to reflect each local area. Following this data analysis, we will invite some interviewees to attend a discussion group (or focus group). In the focus groups we will discuss our findings and their potential to inform recommendations for improvements to PSFU.
Sharing our findings
We will prioritise sharing our final report with study participants and participating NHS organisations, through reports, posters and online workshops, and will use these forums to seek feedback on our findings and proposed recommendations.
Funding amount
£162,922
Funder
Team
Principal Investigators

Dr Katie Sutton
Research Fellow
Biography
Katie is a Post-Doctoral Research Fellow at the University of Surrey with a focus on qualitative research in cancer care and patient experience. She has 15 years experience as a cancer nurse, working mainly in chemotherapy. Katie also led a project to implement stratified follow-up at a large Cancer Centre, which fuelled her passion to carry out more research into personalised cancer care. Katie's PhD explored the perceptions and experiences of people with glioblastoma and how nurses can best support them to maintain their wellbeing.

Professor Jo Armes
Professor of Cancer Care and Lead for Digital Health
Biography
Jo is a Registered Nurse and worked clinically in haematology and medical/clinical oncology before moving to St Bartholomew's & Homerton Hospitals to undertake psycho-oncology research. On completion of a BSc in Nursing Studies at The University of Hull she took up a research post at St Christopher's Hospice, London. In 2000 she was awarded a CRUK Nursing Fellowship to undertake a PhD at King's College London, during which she developed and tested a behavioural intervention for cancer-related fatigue. Subsequently she held a number of academic posts and led the Supportive Cancer Care Research Group in the Florence Nightingale Faculty of Nursing and Midwifery at King's College London. Jo joined the School of Health Sciences at the University of Surrey in 2017 as Reader and Lead for Digital Health. She also leads Digital Innovation theme for the NIHR Applied Research Collaboration for Kent Surrey & Sussex (ARC KSS). Jo has considerable expertise in clinical trials of complex interventions, including digital health interventions, mixed methods and experience based co-design methods.

Dr Verna Lavender
Visiting Associate Professor
Biography
Dr Verna Lavender is the Head of Nursing for Research and Education in Cancer and Surgery at Guy’s and St Thomas’ NHS Foundation Trust and a NIHR Nursing and Midwifery Senior Research Lead. She is a visiting associate professor at the University of Surrey, senior lecturer at King’s College London and a Past President of the UK Oncology Nursing Society.
Verna is a recognised cancer nurse academic with expertise in cancer nursing and cancer nurse education. Her current research interest is personalised cancer care and equitable access to cancer care. She has extensive experience on national cancer care education committees and boards and has published widely on in the field of cancer nursing. She co-authored the UKONS SACT Competence Learning Outcomes Framework in February 2019, authored the UKONS SACT Administration Position Statement, chaired the National Acute Oncology Education Group, led the CASCADE project to develop and evaluate national, multidisciplinary acute oncology competence assessment passports, and is an original member of the NHS England ACCEND Steering Group.
Research groups and centres
Our research is supported by research groups and centres of excellence.